FDA new drug approvals in Q3 2020

被引：3

作者：

Urquhart, Lisa ^{[1
]}

机构：

[1] Evaluate Vantage, London, England

来源：

关键词：

D O I：

10.1038/d41573-020-00182-1

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：746 / 746

页数：1

共 50 条

[1] FDA new drug approvals in Q3 2020
Lisa Urquhart
[J]. Nature Reviews Drug Discovery, 2020, 19 : 746 - 746
[2] FDA new drug approvals in Q3 2022
Brown, Amy
[J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (11) : 788 - 788
[3] FDA new drug approvals in Q3 2021
Urquhart, Lisa
[J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) : 807 - 807
[4] FDA new drug approvals in Q3 2019
Lisa Urquhart
[J]. Nature Reviews Drug Discovery, 2019, 18 : 816 - 816
[5] FDA new drug approvals in Q3 2023
Verdin, Paul
[J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (12) : 946 - 946
[6] FDA new drug approvals in Q3 2019
Urquhart, Lisa
[J]. NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (11) : 816 - 816
[7] FDA new drug approvals in Q3 2022
Amy Brown
[J]. Nature Reviews Drug Discovery, 2022, 21 : 788 - 788
[8] FDA new drug approvals in Q3 2018
Urquhart, Lisa
[J]. NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (11) : 779 - 779
[9] FDA new drug approvals in Q3 2021
Lisa Urquhart
[J]. Nature Reviews Drug Discovery, 2021, 20 : 807 - 807
[10] FDA new drug approvals in Q3 2018
Lisa Urquhart
[J]. Nature Reviews Drug Discovery, 2018, 17 : 779 - 779